Full Press Release Details
NEW BRUNSWICK, N.J. , Sept. 20, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 18 th , to review third-quarter results. Dominic Caruso , Executive Vice President, Chief Financial Officer, Joaquin Duato , Executive Vice President, Worldwide Chairman, Pharmaceuticals, Dr. William Hait , MD. PhD, Global Head Janssen Research & Development, LLC, and Joseph J. Wolk , Vice President, Investor Relations, will host the call.
Investors and other interested parties may access the conference call in the following ways:
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,500 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
SOURCE Johnson & Johnson